Home LiteratureArticle Details
PMID: 6190975 Published · ppublish English Journal Article

Protective Plasmodium knowlesi Mr 74,000 antigen in membranes of schizont-infected rhesus erythrocytes.

The Journal of experimental medicine ·Vol. 158 ·No. 1 ·1983-07-01 ·Pages 146-58

Schmidt-Ullrich R, Lightholder J, Monroe MT

Abstract

The immunogenic Plasmodium knowlesi (H strain) Mr 74,000 protein in membranes of schizont-infected rhesus erythrocytes was purified on a large scale, free of other polypeptides as monitored by dodecyl sulfate polyacrylamide gel electrophoresis and isoelectric focusing. In a limited vaccination trial, four rhesus monkeys were immunized four consecutive times with the Mr 74,000 protein and Freund's complete and incomplete adjuvants. Two monkeys were injected with adjuvant only. Upon challenge with 10(4) viable P. knowlesi schizonts of the heterologous W strain, the control monkeys developed fatal parasitemias after 7 d. In contrast, the vaccinated monkeys exhibited a delayed onset of patent parasitemias and underwent self-cure on days 14 to 16 after peak parasitemias of between 7 and 11%. The protective immunity that was induced crossed different strains of P. knowlesi. Blood smears at the time of cure demonstrated limited reinfection, as indicated by the presence of normally appearing ring and trophozoite stages. The absence of schizont stages in the peripheral blood suggested a specific interruption of the erythrocytic schizogony at that stage. Immunochemical analyses of the rhesus sera revealed antibody only against the Mr 74,000 protein after the first two immunizations. Upon repeated antigen injection, antibodies reacted with components of Mr of approximately 102,000, 140,000, and 230,000 in addition to the Mr 74,000 protein. Besides immunological cross-reactivity, relatedness between all four immune-precipitated proteins was indicated by a greater than 50% tryptic peptide homology, suggesting that the Mr 230,000 component represents a precursor protein that is cleaved within the infected erythrocyte into proteins with Mr of approximately 140,000, 102,000, and 74,000.

MeSH Terms
Animals Antibodies/analysis Antigens/immunology,isolation & purification Epitopes/immunology Erythrocyte Membrane/parasitology Erythrocytes/parasitology Immunization, Secondary Macaca mulatta Malaria/immunology,prevention & control Male Molecular Weight Plasmodium/immunology Vaccination
Chemicals
Antibodies Antigens Epitopes
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Schmidt-Ullrich R
Lightholder J
Monroe M T
References (31)
31 references, click to expand
  1. Plasmodium lophurae: immunogenicity of a histidine-rich protein.
    Exp Parasitol. 1981 Oct;52(2):291 PMID: 7274372
  2. Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response.
    Immunol Rev. 1982;61:245-69 PMID: 6174413
  3. Quantitative determination of soluble and membrane proteins through their native fluorescence.
    Naturwissenschaften. 1971 Apr;58(4):220 PMID: 5574193
  4. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  5. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.
    Nature. 1980 Mar 27;284(5754):366-8 PMID: 7360274
  6. Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts.
    J Exp Med. 1980 Apr 1;151(4):790-8 PMID: 6154761
  7. A freeze-dried merozoite vaccine effective against Plasmodium knowlesi malaria.
    Clin Exp Immunol. 1977 May;28(2):276-9 PMID: 406111
  8. Inhibitory effects of immune monkey serum on synchronized Plasmodium falciparum cultures.
    Am J Trop Med Hyg. 1981 Jan;30(1):12-9 PMID: 7011066
  9. Simian virus 40 (SV40)-specific isoelectric point-4.7--94,000-Mr membrane glycoprotein: major peptide homology exhibited with the nuclear and membrane-associated 94,000-Mr SV40 T-antigen in hamsters.
    J Natl Cancer Inst. 1982 Oct;69(4):839-49 PMID: 6288993
  10. Rhesus monkeys protected against Plasmodium knowlesi malaria produce antibodies against a 65,000-MrP. knowlesi glycoprotein at the surface of infected erythrocytes.
    Infect Immun. 1981 Nov;34(2):519-25 PMID: 7309238
  11. DEMONSTRATION OF PASSIVE IMMUNITY IN EXPERIMENTAL MONKEY MALARIA.
    J Exp Med. 1937 Jul 31;66(2):177-90 PMID: 19870655
  12. Humoral immunity in rodent malaria. III: Studies on the site of antibody action.
    J Immunol. 1975 Apr;114(4):1243-7 PMID: 1090670
  13. Immunisation against gametes and asexual erythrocytic stages of a rodent malaria parasite.
    Nature. 1979 Feb 1;277(5695):389-91 PMID: 551260
  14. Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein.
    J Biol Chem. 1977 Sep 25;252(18):6510-5 PMID: 893422
  15. Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro.
    Nature. 1982 Jun 17;297(5867):591-3 PMID: 7045680
  16. Altered expression of Plasmodium knowlesi variant antigen on the erythrocyte membrane in splenectomized rhesus monkeys.
    J Immunol. 1982 Jan;128(1):224-6 PMID: 6172478
  17. Characterization of antigens from erythrocytic stages of Plasmodium falciparum reacting with human immune sera.
    Trans R Soc Trop Med Hyg. 1981;75(1):163-5 PMID: 7022789
  18. Immunization against blood-stage rodent malaria using purified parasite antigens.
    Nature. 1981 Nov 26;294(5839):361-4 PMID: 7312033
  19. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.
    J Exp Med. 1980 Jun 1;151(6):1504-13 PMID: 6991628
  20. Malaria immunization in Rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi.
    J Exp Med. 1978 Nov 1;148(5):1311-23 PMID: 102724
  21. Plasmodium knowlesi-induced antigens in membranes of parasitized rhesus monkey erythrocytes.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):4949-53 PMID: 105359
  22. Plasmodium lophurae: protective immunogenicity of the histidine-rich protein?
    Exp Parasitol. 1981 Oct;52(2):292-5 PMID: 7274373
  23. Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi.
    Nature. 1965 Dec 25;208(5017):1286-8 PMID: 4958335
  24. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
    Biochem J. 1963 Oct;89:114-23 PMID: 14097352
  25. Fractionation of Plasmodium knowlesi-induced antigens of rhesus monkey erythrocyte membranes.
    Bull World Health Organ. 1979;57 Suppl 1:115-21 PMID: 120762
  26. Histidine-rich protein as a model malaria vaccine.
    Science. 1978 Sep 8;201(4359):922-4 PMID: 567375
  27. Gamma-globulin and acquired immunity to human malaria.
    Nature. 1961 Nov 25;192:733-7 PMID: 13880318
  28. Antigenic variation and protective immunity in Plasmodium knowlesi malaria.
    Immunology. 1972 Oct;23(4):503-21 PMID: 4628462
  29. Immunogenic antigens common to Plasmodium knowlesi and Plasmodium falciparum are expressed on the surface of infected erythrocytes.
    J Parasitol. 1982 Apr;68(2):185-93 PMID: 7042947
  30. Antigenic analysis of sequential erythrocytic stages of Plasmodium knowlesi.
    Parasitology. 1978 Dec;77(3):333-44 PMID: 107503
  31. Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies.
    Nature. 1981 Jan 22;289(5795):301-3 PMID: 6161311
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1983-07-01
Pages
146-58
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2187067
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]